Trial Profile
First in human study of KPI-150
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 11 Aug 2016
Price :
$35
*
At a glance
- Drugs KPI 150 (Primary)
- Indications Atopic dermatitis; Cutaneous lupus erythematosus; Psoriasis
- Focus Adverse reactions; First in man
- 11 Aug 2016 According to company's pipeline, this study is expected to start by late 2016 or early 2017.
- 11 Aug 2016 New trial record